Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus.

Riedel DJ, Weekes E, Forrest GN.

Antimicrob Agents Chemother. 2008 Jul;52(7):2463-7. doi: 10.1128/AAC.00300-08. Epub 2008 May 12.

2.

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.

Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.

Clin Infect Dis. 2009 Mar 15;48(6):713-21. doi: 10.1086/597031.

PMID:
19207079
3.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S. aureus Endocarditis and Bacteremia Study Group.

N Engl J Med. 2006 Aug 17;355(7):653-65.

4.

Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.

Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J.

Arch Intern Med. 1999 Mar 8;159(5):473-5.

PMID:
10074955
5.

A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.

Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.

Medicine (Baltimore). 2003 Sep;82(5):322-32.

6.
7.

Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study.

Shrestha NK, Shah SY, Wang H, Hussain ST, Pettersson GB, Nowacki AS, Gordon SM.

Ann Thorac Surg. 2016 Jun;101(6):2243-50. doi: 10.1016/j.athoracsur.2015.11.015. Epub 2016 Feb 10.

PMID:
26872729
8.

Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection.

Kuo CB, Lin JC, Peng MY, Wang NC, Chang FY.

J Microbiol Immunol Infect. 2007 Aug;40(4):317-24.

PMID:
17712466
9.

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.

Medicine (Baltimore). 2003 Sep;82(5):333-9.

11.

Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.

Cervera C, del Río A, García L, Sala M, Almela M, Moreno A, Falces C, Mestres CA, Marco F, Robau M, Gatell JM, Miró JM; Hospital Clinic Endocarditis Study Group.

Enferm Infecc Microbiol Clin. 2011 Oct;29(8):587-92. doi: 10.1016/j.eimc.2011.05.007. Epub 2011 Jun 30.

PMID:
21723004
12.

Staphylococcus capitis endocarditis: two cases and review of the literature.

Sandoe JA, Kerr KG, Reynolds GW, Jain S.

Heart. 1999 Sep;82(3):e1. Review.

13.

Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.

Karchmer AW.

Am J Med. 1985 Jun 28;78(6B):116-27. Review.

PMID:
3893113
14.

Infective endocarditis at autopsy: a review of pathologic manifestations and clinical correlates.

Fernández Guerrero ML, Álvarez B, Manzarbeitia F, Renedo G.

Medicine (Baltimore). 2012 May;91(3):152-64. doi: 10.1097/MD.0b013e31825631ea.

15.

Staphylococcus aureus bacteremia and endocarditis.

Chang FY.

J Microbiol Immunol Infect. 2000 Jun;33(2):63-8. Review.

PMID:
10917874
16.

Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis.

Brown J, Brown KA, Forrest A.

Clin Ther. 2011 Oct;33(10):1475-82. doi: 10.1016/j.clinthera.2011.08.011. Epub 2011 Sep 16.

PMID:
21925733
17.

Influence of pathogenetic factors on prognosis in patients with native valve infective endocarditis.

Abramczuk E, Hryniewiecki T, Stepińska J.

Kardiol Pol. 2006 Jul;64(7):675-81; discussion 682-3.

18.

Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.

Fernández Guerrero ML, González López JJ, Goyenechea A, Fraile J, de Górgolas M.

Medicine (Baltimore). 2009 Jan;88(1):1-22. doi: 10.1097/MD.0b013e318194da65.

19.
20.

Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.

Ahmad NM, Rojtman AD.

Ann Pharmacother. 2010 May;44(5):918-21. doi: 10.1345/aph.1M665. Epub 2010 Mar 30.

PMID:
20354160

Supplemental Content

Support Center